Add 500 million yuan to unnamed medicine and build a new CMO original solution production line
-
Last Update: 2018-11-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On November 28, Weiming pharmaceutical announced that the company plans to add 500 million yuan of investment in phase II construction project of Beida Weiming biological CMO, a wholly-owned subsidiary, with its own funds The project is planned to start in early January 2019 with a minimum construction period of 18 months According to the announcement, the specific contents of the second phase of the construction project include: 1 Build 2 * 1000L and 2 * 2000L CMO original solution production lines; 2 Establish an international professional production and operation team; 3 Some production lines put into use have passed GMP / FDA / EU / who and other international certification; 4 Strengthen the technical cooperation of international high-quality products The full text of the announcement is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
